D. V. Vlahakos, K. P. Marathias, B. Agroyannis, and N. E. Madias, Kidney Int, vol.63, pp.1187-94, 2003.

C. G. Wickre, D. J. Norman, A. Bennison, J. M. Barry, and W. M. Bennett, Postrenal transplant erythrocytosis: A review of 53 patients, Kidney Int, vol.23, pp.731-738, 1983.

L. F. Morrone, D. Paolo, S. Logoluso, and F. , Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: Role of growth factors and cytokines, Transplantation, vol.64, pp.913-921, 1997.

M. Perazella, P. Mcphedran, A. Kliger, M. Lorber, E. Levy et al., Enalapril treatment of posttransplant erythrocytosis: Efficacy independent of circulating erythropoietin levels, Am J Kidney Dis, vol.26, pp.495-500, 1995.

K. Koziak, K. Rell, M. Lao, T. Baczkowska, and Z. Gaciong, Does erythropoietin production after renal transplantation depend on the type of immunosuppression?, Nephron, vol.71, pp.236-243, 1995.

R. S. Gaston, B. A. Julian, and J. J. Curtis, Posttransplant erythrocytosis: An enigma revisited, Am J Kidney Dis, vol.24, pp.1-11, 1994.
DOI : 10.1016/s0272-6386(12)80153-3

M. Kessler, D. Hestin, D. Mayeux, P. M. Mertes, and E. Renoult, Factors predisposing to post-renal transplant erythrocytosis. A prospective matchedpair control study, Clin Nephrol, vol.45, pp.83-92, 1996.

F. J. Dagher, E. Ramos, A. Erslev, S. Karmi, and S. V. Alongi, Erythrocytosis after renal allotransplantation: Treatment by removal of the native kidneys, South Med J, vol.73, pp.940-942, 1980.

M. Gupta, B. A. Miller, N. Ahsan, P. J. Ulsh, M. Y. Zhang et al., Expression of angiotensin II type I receptor on erythroid progenitors of patients with posttransplant erythrocytosis, Transplantation, vol.70, pp.1188-94, 2000.

R. S. Gaston, B. A. Julian, C. V. Barker, A. G. Diethelm, and J. J. Curtis, Enalapril: Safe and effective therapy for posttransplant erythrocytosis, Transplant Proc, vol.25, pp.1029-1060, 1993.

M. Azizi, A. Rousseau, and E. Ezan, Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysylproline, J Clin Invest, vol.97, pp.839-883, 1996.

P. N. Correa and A. A. Axelrad, Production of eryhtropoietin bursts by progenitor cells from adult human peripheral blood in an improved serum free medium: Role of insulin-like growth factor 1, Blood, vol.78, pp.2823-2856, 1991.

M. Sanders, S. Sorba, and N. Dainiak, Insulin-like growth factors stimulate erythropoiesis in serum-substituted unbilical cord blood cultures

, Exp Hematol, vol.21, pp.25-30, 1993.

L. F. Congote, A. Brox, F. K. Lin, H. S. Lu, and A. A. Fauser, The N-terminal sequence of the major erythropoietic factor of an anephric patient is identical to insulin-like growth factor 1, J Clin Endocrinol Metab, vol.72, pp.727-736, 1991.

P. Urena, A. Bonnardeaux, K. U. Eckardt, A. Kurtz, and T. B. Drüeke, Insulin-like growth factor I: A modulator of erythropoiesis in uraemic patients?, Nephrol Dial Transplant, vol.7, pp.40-44, 1992.

A. A. Kiykim, G. Genctoy, and M. Horoz, Serum stem cell factor level in renal transplant recipients with posttransplant erythrocytosis, Artif Organs, vol.33, pp.1086-90, 2009.
DOI : 10.1111/j.1525-1594.2009.00823.x

C. Maktouf, A. Bounemra, and S. Mahjoub, Evaluation of serum VEGF levels in untreated erythrocytosis patients, Pathol Biol (Paris), vol.59, pp.240-242, 2011.
URL : https://hal.archives-ouvertes.fr/pasteur-01375283